Is Precise delivery of interventional medical devices, especially when treating challenging lesions, critical to a successful outcomes for patients, and VOYAGER NC has excellent deliverability, said Charles Simonton, divisional vice president, Medical Affairs, and Chief medical officer, Abbott Vascular. The launch of VOYAGER NC underscores Abbott ‘s ongoing commitment to innovative technologies to market from our broad, vascular pipeline. .
About AbbottAbbott is a global, broad – based health care company which, to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals high-pressure The company employs more than 72,000 people and markets its products in more than 130 countries.Furthermore Four further forms of preleukaemic affecting the bone marrow in the exposed group and No case in the control. The incidence of leukemia was insignificant the control group to the control group the expected value to a normal population.